The Prognostic Value of miR-21 and miR-155 in Non-small-cell Lung Cancer: A Meta-analysis

High Expression of MicroRNA-210 is an Independent Factor Indicating a Poor Prognosis in Japanese Triple-negative Breast Cancer Patients

(2012) T. Toyama et al.   JAPANESE JOURNAL OF CLINICAL ONCOLOGY

Systematic Lymphadenectomy for Survival in Patients with Endometrial Cancer: A Meta-analysis

(2012) H. S. Kim et al.   JAPANESE JOURNAL OF CLINICAL ONCOLOGY

The Association of MicroRNA Expression with Prognosis and Progression in Early-Stage, Non-Small Cell Lung Adenocarcinoma: A Retrospective Analysis of Three Cohorts

(2011) M. Saito et al.   CLINICAL CANCER RESEARCH

Prognostic significance of serum miRNA-21 expression in human non-small cell lung cancer

(2011) Zhao-Xia Wang et al.   JOURNAL OF SURGICAL ONCOLOGY

Prognostic Impact of MiR-155 in Non-Small Cell Lung Cancer Evaluated by in Situ Hybridization

(2011) Tom Donnem et al.   Journal of Translational Medicine

High expression of serum miR-21 and tumor miR-200c associated with poor prognosis in patients with lung cancer

(2011) Xiao-Guang Liu et al.   MEDICAL ONCOLOGY

Deregulated expression of miR-21, miR-143 and miR-181a in non small cell lung cancer is related to clinicopathologic characteristics or patient prognosis

(2010) Wen Gao et al.   BIOMEDICINE & PHARMACOTHERAPY

MicroRNA Expression and Clinical Outcomes in Patients Treated with Adjuvant Chemotherapy after Complete Resection of Non-Small Cell Lung Carcinoma

(2010) J. Voortman et al.   CANCER RESEARCH

MicroRNA-21 (miR-21) represses tumor suppressor PTEN and promotes growth and invasion in non-small cell lung cancer (NSCLC)

(2010) Ji-guang Zhang et al.   CLINICA CHIMICA ACTA

Fluorescence-Based Codetection with Protein Markers Reveals Distinct Cellular Compartments for Altered MicroRNA Expression in Solid Tumors

(2010) L. F. Sempere et al.   CLINICAL CANCER RESEARCH

Early detection of lung adenocarcinoma in sputum by a panel of microRNA markers

(2010) Lei Yu et al.   INTERNATIONAL JOURNAL OF CANCER

MiR-21 overexpression in human primary squamous cell lung carcinoma is associated with poor patient prognosis

(2010) Wen Gao et al.   JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY

The International Association for the Study of Lung Cancer Staging Project: Prognostic Factors and Pathologic TNM Stage in Surgically Managed Non-small Cell Lung Cancer

(2010) Kari Chansky et al.   Journal of Thoracic Oncology

Downregulation of miR-21 inhibits EGFR pathway and suppresses the growth of human glioblastoma cells independent of PTEN status

(2010) Xuan Zhou et al.   LABORATORY INVESTIGATION

Relationship between XRCC3 T241M polymorphism and gastric cancer risk: a meta-analysis

(2010) Fang Fang et al.   MEDICAL ONCOLOGY

Polymorphism of vascular endothelial growth factor –2578C/A with cancer risk: evidence from 11263 subjects

(2010) Chao Cao et al.   MEDICAL ONCOLOGY

TP53 Arg72Pro polymorphism and endometrial cancer risk: a meta-analysis

(2010) De-Ke Jiang et al.   MEDICAL ONCOLOGY

STAT3 Activation of miR-21 and miR-181b-1 via PTEN and CYLD Are Part of the Epigenetic Switch Linking Inflammation to Cancer

(2010) Dimitrios Iliopoulos et al.   MOLECULAR CELL

MicroRNA Classifiers for Predicting Prognosis of Squamous Cell Lung Cancer

(2009) M. Raponi et al.   CANCER RESEARCH

MiR-21 is an EGFR-regulated anti-apoptotic factor in lung cancer in never-smokers

(2009) M. Seike et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Prognostic Value of Mature MicroRNA-21 and MicroRNA-205 Overexpression in Non-Small Cell Lung Cancer by Quantitative Real-Time RT-PCR

(2008) A. Markou et al.   CLINICAL CHEMISTRY

miR-21: a small multi-faceted RNA

(2008) Anna M. Krichevsky et al.   JOURNAL OF CELLULAR AND MOLECULAR MEDICINE

MicroRNA miR-21 overexpression in human breast cancer is associated with advanced clinical stage, lymph node metastasis and patient poor prognosis

(2008) L.-X. Yan et al.   RNA